Dianthus Therapeutics, Inc. /DE/ (DNTH) ROE
- 2026-06-30: ROE -16.40%.
- 2026-03-31: ROE -14.46%.
- 2025-12-31: ROE -32.90%.
- 2025-09-30: ROE -23.12%.
Complete source-backed roe history.
- Available history
- 2016-12-31 to 2026-06-30
- Data captured
Historical ROE
| Date | ROE |
|---|
| 2026-06-30 | -16.40% |
|---|
| 2026-03-31 | -14.46% |
|---|
| 2025-12-31 | -32.90% |
|---|
| 2025-09-30 | -23.12% |
|---|
| 2025-06-30 | -37.86% |
|---|
| 2025-03-31 | -30.65% |
|---|
| 2024-12-31 | -24.11% |
|---|
| 2024-09-30 | -19.86% |
|---|
| 2024-06-30 | -15.82% |
|---|
| 2024-03-31 | -13.47% |
|---|
| 2023-12-31 | -25.79% |
|---|
| 2023-09-30 | -24.17% |
|---|
| 2023-06-30 | 58.78% |
|---|
| 2023-03-31 | 60.38% |
|---|
| 2022-12-31 | 64.18% |
|---|
| 2022-09-30 | 108.34% |
|---|
| 2022-06-30 | 172.10% |
|---|
| 2022-03-31 | 265.25% |
|---|
| 2021-12-31 | 412.41% |
|---|
| 2021-09-30 | -36.91% |
|---|
| 2021-06-30 | -34.63% |
|---|
| 2021-03-31 | -56.11% |
|---|
| 2020-12-31 | -52.07% |
|---|
| 2020-09-30 | -50.46% |
|---|
| 2020-06-30 | -47.91% |
|---|
| 2020-03-31 | -65.35% |
|---|
| 2019-12-31 | -54.37% |
|---|
| 2019-09-30 | -43.47% |
|---|
| 2019-06-30 | -36.33% |
|---|
| 2019-03-31 | -45.66% |
|---|
| 2018-12-31 | -39.49% |
|---|
| 2018-09-30 | -30.59% |
|---|
| 2018-06-30 | -23.09% |
|---|
| 2018-03-31 | 80.69% |
|---|
Annual ROE
| Date | ROE |
|---|
| 2025-12-31 | -32.90% |
|---|
| 2024-12-31 | -24.11% |
|---|
| 2023-12-31 | -25.79% |
|---|
| 2022-12-31 | 64.18% |
|---|
| 2021-12-31 | 412.41% |
|---|
| 2020-12-31 | -52.07% |
|---|
| 2019-12-31 | -54.37% |
|---|
| 2018-12-31 | -39.49% |
|---|
| 2017-12-31 | 84.27% |
|---|
| 2016-12-31 | 106.28% |
|---|
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
|---|
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
|---|
| Veradermics, Inc (MANE) | United States | $4.839B | |
|---|
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
|---|
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
|---|
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
|---|
| Edgewise Therapeutics, Inc. (EWTX) | United States | $4.470B | -22.23 |
|---|
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
|---|
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
|---|
| Viking Therapeutics, Inc. (VKTX) | United States | $4.287B | -8.51 |
|---|